Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Dr Mark Bullimore weighs in on recent FDA marketing authorization of Stellest lenses | Optometry Times - Clinical News & Expert Optometrist Insights
Published on October 1, 2025
Continue reading on website
Other news
Taiwanese Study Using Population-based Polygenic Risk Score Effectively Predicted POAG
October 1, 2025
The most significant locus identified in the genome-wide association study was near the KYNU gene, which hasn’t been reported before in genetic POAG studies. KYNU encodes kynurenine, and the pathway this enzyme plays a key role in has been linked to mitochondrial dysfunction and a range of neurodegenerative conditions—including glaucoma—with reduced levels. Photo: Michael Chaglasian, OD. Click im
EssilorLuxottica Completes Acquisition of Optegra
October 2, 2025
PARIS—EssilorLuxottica (Reuters: ESLX.PA) announced yesterday that it has successfully completed the acquisition of Optegra from MidEuropa. In making the announcement, the company noted that “Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities.” Under the Optegra, Lexum and Iris brands, the announc